Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Trading Update

22 Nov 2019 07:00

RNS Number : 2918U
Science in Sport PLC
22 November 2019
 

 

22 November 2019

 

 

 

SCIENCE IN SPORT PLC

("Company" or "Group")

Trading Update

 

Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces an update on trading to date for the financial year ending 31 December 2019.

 

2019 has seen rapid progress at the Company. The integration of the PhD acquisition has been completed on time, with synergies already being achieved in line with plan, and the growth rate of the PhD brand has doubled over historic rates. The SiS brand has continued to grow strongly, in line with its six-year compound annual growth rate of more than 25%. Growth from the strategic priorities of both e-commerce and international markets has also been strong.

 

As a result, total sales growth for the year to 31 December 2019 is expected to be slightly ahead of market expectations, with sales momentum into 2020 underpinned by operational progress including a new PhD.com e-commerce platform and a new protein powder line, which is now in full production.

 

During the current half, the Group has absorbed a global whey price increase and also a foreign exchange effect relating to very strong sales of Smart Bars. As a consequence, the previously expected small EBITDA profit of £0.3m for the year is now anticipated to be a small EBITDA loss.

 

Cash balances at the year-end are expected to be in line with management expectations at approximately £5.3m.

 

The outlook for the remaining few weeks of the current year and for 2020 continues to be strong, underpinned by a robust innovation pipeline, the current year's operational progress and a continued strategic focus on e-commerce and international markets.

 

The Company will issue its full year trading update for the year ending 31 December 2019 in the week commencing 13 January 2020.

 

Stephen Moon, Science in Sport's Chief Executive Officer, commented:

"Our strategy is on-track and, in the year to 31 December 2019, we expect a record year of growth from PhD and another year of consistently high growth from SiS. The integration of PhD completed as planned and we are already seeing strong trading metrics from the PhD.com website in addition to significantly improved efficiencies in our new e-commerce fulfilment unit. Our in-house protein powder line was launched earlier this week, on time and under budget.

 

"The Board remains confident about the outlook for 2020 and beyond as we invest in our growth priorities of e-commerce and international markets. Gross margin remains robust, costs are tightly controlled and our cash position is healthy, allowing us to be confident in our long term growth trajectory."

 

 

For further information:

 

Science in Sport plc

Stephen Moon, Chief Executive Officer

James Simpson, Chief Financial Officer

+44 (0) 20 7400 3700

LiberumNominated adviser and broker

Bidhi BhomaJames Greenwood

+44 (0) 20 3100 2000

Buchanan CommunicationsFinancial PR

Mark CourtVicky HaynsTilly Abraham

+44 (0) 20 7466 5000

ScienceInSport@buchanan.uk.com

 

 

Notes to Editors

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands: PhD Nutrition, a premium protein brand targeting gym lifestyle and sports enthusiasts, and SiS, a leading brand among elite athletes and professional sports teams.

The two brands are sold internationally through multiple retail channels, both traditional and online, including major supermarkets and high street chains, specialist sports retailers and e-commerce sites including Amazon and the brands' own websites. They enable the Company to address the full breadth of the performance nutrition market currently estimated at approximately £10 billion worldwide.

PhD is one of the UK's leading protein brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since launch in 2005. The range now comprises powders, bars, flapjacks, drinks and other products including the high protein, low sugar range, PhD Smart. PhD is the exclusive sports nutrition supplier to David Lloyd Clubs and its brand ambassadors include rapper Bugzy Malone, WBA international champion Jordan Gill and Team GB Olympic sprinter Asha Philip.

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and endurance. SiS is the official sports nutrition supplier to many professional cycling teams and organisations including Team INEOS, British Cycling, Cycling Australia, USA Cycling and USA Triathlon. SiS supplies more than 80 professional football clubs in the UK and is an official partner to British Triathlon and the Rock 'n' Roll Marathon Series. SiS brand ambassadors include Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE.

Science in Sport is headquartered in London. Its shares joined the AIM market of the London Stock Exchange in August 2013 and trade under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLFFLLLSLLFIA
Date   Source Headline
8th May 202510:34 amRNSForm 8.5 (EPT/RI)
7th May 20253:04 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th May 20257:00 amRNSPublication of Scheme Document
2nd May 20254:11 pmRNSDisclosure under Rule 2.10 of the Takeover Code
2nd May 20252:31 pmRNSForm 8.3 - Science in Sport PLC
2nd May 20259:07 amRNSForm 8 (OPD) Science in sport plc
1st May 202510:40 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
30th Apr 202511:09 amRNSForm 8.3 - Science in Sport PLC
30th Apr 20259:59 amBUSForm 8.3 - Science in Sport PLC
30th Apr 20258:53 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
30th Apr 20258:11 amRNS2024 Annual Report
29th Apr 20259:38 amBUSForm 8.3 - Science in Sport PLC
28th Apr 20257:00 amRNSFinal Results
25th Apr 202512:04 pmRNSForm 8.3 - Science in Sport plc
25th Apr 20259:38 amBUSForm 8.3 - Science in Sport plc
24th Apr 20255:01 pmRNSForm 8.3 - Science in Sport plc
24th Apr 20259:45 amBUSForm 8.3 - Science in Sport PLC
24th Apr 20259:37 amPRNForm 8.3 - Science In Sport Plc
23rd Apr 20255:08 pmBUSForm 8.3 - Science in Sport Plc
23rd Apr 20255:00 pmRNSForm 8.3 – Science in Sport plc
23rd Apr 202511:11 amRNSForm 8.5 (EPT/RI)
22nd Apr 20251:46 pmRNSForm 8.3 - Science in Sport PLC
22nd Apr 20251:44 pmRNSTR-1: Notification of Major Holdings
22nd Apr 202511:58 amRNSForm 8.3 - Science in Sport PLC
22nd Apr 202510:59 amRNSForm 8.5 (EPT/RI)
22nd Apr 20258:12 amGNWForm 8.5 (EPT/RI)-Science in Sport plc
17th Apr 20253:06 pmRNSForm 8.3 - Science in Sport
17th Apr 20252:52 pmGNWForm 8.3 - [SCIENCE IN SPORT PLC - Opening Disclosure - 16 04 2025] - (CGAML)
17th Apr 20252:46 pmRNSForm 8.3 - Science in Sport PLC
17th Apr 20252:39 pmRNSRecommended Cash Acquisition
17th Apr 20252:01 pmRNSForm 8.3 - Science in Sport plc
17th Apr 202512:50 pmRNSForm 8.3 - Science in Sport Plc
17th Apr 202511:46 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:25 amRNSForm 8.5 (EPT/RI) - Replacement
17th Apr 202510:08 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:05 amRNSForm 8.5 (EPT/RI)- Science in Sport plc
17th Apr 20259:04 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
16th Apr 20252:36 pmRNSPossible Offer Clarification
16th Apr 20251:49 pmRNSPossible Offer
30th Jan 20257:00 amRNSTrading Statement
21st Nov 20245:32 pmRNSNotification of major holdings
27th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSNotification of Major Holdings
18th Sep 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSInterim Results
15th Aug 20248:48 amRNSReplacement: Result of Annual General Meeting
31st Jul 20245:03 pmRNSResult of Annual General Meeting
31st Jul 20244:01 pmRNSNotification of Major Holdings
31st Jul 20244:00 pmRNSReplacement: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.